Darling Ingredients Inc (DAR) Stock News

IonQ and IBM have advanced to Stage C of DARPA's Quantum Benchmarking Initiative, which provides up to $300 million in funding to develop commercially viable fault-tolerant quantum computers by 2033. IonQ leads in accuracy with 99.99% 2-qubit gate fidelity and recent quantum error-correction breakthroughs, while IBM pursues a faster superconducting qubit approach with ambitious plans for a fault-tolerant system by 2029.

Diraq, a quantum computing company, has been selected by DARPA to advance to Stage C of the Quantum Benchmarking Initiative, the final stage of evaluating quantum computing approaches for utility-scale operation by 2033. The company will receive an initial $51 million tranche with up to $300 million total funding to validate its silicon-based quantum computing systems. Diraq plans to deploy the world's first silicon spin quantum computer in a commercial data center at Equinix in Sydney before the end of 2026 and aims to achieve utility scale by 2031 with over 2 million physical qubits.

ADARx Pharmaceuticals, a late-stage clinical biotechnology company developing siRNA therapeutics, priced its IPO at $17 per share for 26.25 million shares, generating approximately $446.3 million in gross proceeds. The company will begin trading on Nasdaq under ticker 'ADRX' on September 25, 2026. AbbVie has agreed to purchase shares in a concurrent private placement for approximately $100 million, resulting in a 4.9% stake in ADARx.

Interactive Brokers reported a 23% year-over-year increase in client DARTs to 4.28 million in August 2026, driven by market volatility from monetary policy shifts, inflation concerns, and geopolitical tensions. The company also saw net new accounts jump 49% y/y and total accounts reach 5.46 million. Strong performance was supported by IBKR's low-cost structure, competitive rates, and efficient operations.

Following the announcement of its proposed merger with WDP, Standard & Poor's has placed ARGAN's BBB- credit rating on CreditWatch with positive outlook, signaling a potential upgrade of at least one notch. S&P cited the merger's expected benefits including increased size, strengthened rental income profile, expanded geographic diversification, and reduced client concentration risk, positioning the combined entity as a European logistics real estate leader.

Following ARGAN's proposed merger with WDP announced on July 23, 2026, Standard & Poor's has placed ARGAN's 'BBB-' issuer credit rating on Positive CreditWatch, indicating a potential upgrade to 'BBB' upon merger completion in Q1 2027. The combined entity would benefit from increased scale, geographic diversification, reduced tenant concentration risk, and a stronger financial profile.

Rosen Law Firm is reminding investors in Sportradar Group AG, Hub Group, Inc., and Commvault Systems, Inc. of upcoming lead plaintiff deadlines in securities class action lawsuits. The Sportradar lawsuit alleges the company made false statements about compliance and worked with black-market gambling operators while misrepresenting its Know-Your-Customer processes. Similar class actions have been filed against the other companies with July 17, 2026 as a key deadline.

A securities class action lawsuit has been filed against Sportradar Group AG (NASDAQ: SRAD) for allegedly making false and misleading statements regarding its compliance practices. The lawsuit claims the company intentionally worked with black-market gambling operators while publicly assuring strict legal and regulatory compliance, and that its Know-Your-Customer (KYC) processes were not as robust as claimed. Investors who purchased shares between November 7, 2024 and April 21, 2026 may be eligible for compensation. The lead plaintiff deadline is July 17, 2026.

Atos has been recognized as a market leader in SAP Services by PAC in their 2026 RADAR evaluation, achieving multiple 'Best in Class' rankings across consulting, system integration, hosting, and application management. The recognition highlights Atos' strong global position, particularly in EMEA, with deep expertise in SAP BTP, cloud solutions, and AI-driven transformation capabilities.

Atos has been recognized by PAC as a leader in the SAP services market for 2026, receiving 'Best in Class' ratings in multiple categories including consulting, systems integration, application management, and SAP hosting. The recognition highlights Atos's strong position in the EMEA region, its comprehensive SAP portfolio, and its strategic focus on SAP BTP, cloud sovereignty, and AI capabilities.

A securities class action lawsuit has been filed against Sportradar Group AG (NASDAQ: SRAD) for allegedly making false and misleading statements regarding compliance practices. The lawsuit claims the company intentionally worked with black-market gambling operators while misrepresenting its Know-Your-Customer processes and regulatory compliance. Investors who purchased shares between November 7, 2024 and April 21, 2026 may be eligible for compensation. The lead plaintiff deadline is July 17, 2026.

ADARx Pharmaceuticals announced that Phase 1/2 clinical data for onvuzosiran (ADX-324), an siRNA therapeutic for hereditary angioedema (HAE), will be presented at the 2026 EAACI Annual Meeting in Istanbul. The drug is designed to reduce plasma kallikrein levels and prevent HAE attacks with reduced treatment burden. Onvuzosiran is currently in Phase 3 STOP-HAE trials and has received FDA Orphan Drug Designation.